Skip to main content
. 2023 Nov 28;11(23):3061. doi: 10.3390/healthcare11233061

Table 11.

Time effects of each domain score on male partners’ health beliefs and self-efficacy.

Baseline Three Months Post-Intervention MD Cohen’s d p-Value 95%CI
[Experimental Group] n Mean (SD) n Mean (SD)
Knowledge of SHS C 140 17.49 (1.11) 140 17.68 (1.03) −0.19 −0.13 0.15 a −0.30, 0.04
Perceived SHS related disease susceptibility D 140 6.40 (1.20) 140 6.36 (0.87) 0.04 0.03 0.74 a −0.13, 0.20
Perceived SHS-related disease severity E 140 6.31 (1.06) 140 6.50 (1.01) −0.19 −0.11 0.15 a −0.28, 0.06
Perceived benefits F 140 12.36 (2.39) 140 12.20 (2.43) 0.16 0.05 0.61 a −0.12, 0.21
Barriers of preventing SHS exposure G 140 11.54 (2.33) 140 12.66 (2.62) −1.12 −0.34 ≤0.01 a −0.51, −0.17
Cue to action for preventing SHS exposure H 140 19.21 (5.61) 140 21.34 (5.23) −2.13 −0.36 ≤0.01 a −0.53, −0.19
Self-efficacy I 140 31.36 (3.80) 140 31.53 (3.89) −0.17 −0.03 0.72 a −0.20, 0.13
[Control group]
Knowledge of SHS C 146 17.33 (1.40) 146 17.67 (1.12) −0.34 −0.18 0.04 a −0.35, −0.02
Perceived SHS related disease susceptibility D 146 6.26 (1.31) 146 6.27 (0.88) −0.01 0.00 0.96 a −0.17, 0.16
Perceived SHS-related disease severity E 146 6.34 (1.14) 146 6.31 (0.92) 0.03 0.02 0.84 a −0.14, 0.18
Perceived benefits F 146 12.15 (2.42) 146 12.04 (1.93) 0.11 0.03 0.70 a −0.13, 0.20
Barriers of preventing SHS exposure G 146 12.14 (2.59) 146 12.86 (2.10) −0.72 −0.23 0.01 a −0.40, −0.07
Cue to action for preventing SHS exposure H 146 18.61 (5.14) 146 19.97 (5.04) −1.36 −0.22 0.01 a −0.39, −0.06
Self-efficacy I 146 31.24 (4.84) 146 31.39 (3.85) −0.15 −0.03 0.80 a −0.19, 0.14

Note. a: Paired t-test was conducted. SHS = second hand smoke; C–I refers to related appendices.